Z-2059-2014 Class II Terminated
FDA device recall Z-2059-2014 was initiated by Mindray DS USA, Inc. Dba Mindray North America on May 19, 2014 and is designated Class II. Reason for recall: ECG interpretation feature issues. False measurements reported when the algorithm cannot determine P wave or QRS axis. The Median Complex Report displays the representative beat 25% larger than… The recall status is terminated (terminated Apr 20, 2017). Affected quantity: 113 units (57 United States; 56 International).
Recall details
- Product Type
- Devices
- Report Date
- Jul 23, 2014
- Initiation Date
- May 19, 2014
- Termination Date
- Apr 20, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 113 units (57 United States; 56 International)
Product description
V-Series Patient Monitoring System, Manufactured for Mindray DS USA, Inc. Used for monitoring of human physiological parameters. The V-Series Monitor also has the capability of performing IV Drug and Hemodynamic Calculations and interfacing with network devices.
Reason for recall
ECG interpretation feature issues. False measurements reported when the algorithm cannot determine P wave or QRS axis. The Median Complex Report displays the representative beat 25% larger than actual signal input. When a patient date of birth is imported from an external source, the ECG interpretation algorithm uses the default age of 50, and interpretive statements may be incorrect.
Distribution pattern
Worldwide Distribution - US including the states of Louisiana, New Jersey, Montana, South Carolina and Wyoming.
Code information
Part Number (P/N): 0998-00-1800-101 and 0998-00-1800-201 with software version 2.4.1.18 in use with 12-lead ECG Module, P/N:0998-00-1804-01 and 0998-00-1804-02.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2059-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026